<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35053260</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>NMR-Based Metabolomic Analysis of Sera in Mouse Models of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">112</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom12010112</ELocationID><Abstract><AbstractText>Viral myocarditis (VMC) is an inflammatory heart condition which can induce dilated cardiomyopathy (DCM). However, molecular mechanisms underlying the progression of VMC into DCM remain exclusive. Here, we established mouse models of VMC and DCM by infecting male BALB/c mice with Coxsackievirus B3 (CVB3), and performed NMR-based metabonomic analyses of mouse sera. The mouse models covered three pathological stages including: acute VMC (aVMC), chronic VMC (cVMC) and DCM. We recorded <sup>1</sup>D <sup>1</sup>H-NMR spectra on serum samples and conducted multivariate statistical analysis on the NMR data. We found that metabolic profiles of these three pathological stages were distinct from their normal controls (CON), and identified significant metabolites primarily responsible for the metabolic distinctions. We identified significantly disturbed metabolic pathways in the aVMC, cVMC and DCM stages relative to CON, including: taurine and hypotaurine metabolism; pyruvate metabolism; glycine, serine and threonine metabolism; glycerolipid metabolism. Additionally, we identified potential biomarkers for discriminating a VMC, cVMC and DCM from CON including: taurine, valine and acetate for aVMC; glycerol, valine and leucine for cVMC; citrate, glycine and isoleucine for DCM. This work lays the basis for mechanistically understanding the progression from acute VMC to DCM, and is beneficial to exploitation of potential biomarkers for prognosis and diagnosis of heart diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Jinping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory for Chemical Biology of Fujian Province, MOE Key Laboratory of Spectrochemical Analysis &amp; Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Ruohan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Key Laboratory for Chemical Biology of Fujian Province, MOE Key Laboratory of Spectrochemical Analysis &amp; Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Caihua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research and Communication Center of Exercise and Health, Xiamen University of Technology, Xiamen 361024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory for Chemical Biology of Fujian Province, MOE Key Laboratory of Spectrochemical Analysis &amp; Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Weifeng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Donghai</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Key Laboratory for Chemical Biology of Fujian Province, MOE Key Laboratory of Spectrochemical Analysis &amp; Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002311" MajorTopicYN="Y">Cardiomyopathy, Dilated</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">1H-NMR</Keyword><Keyword MajorTopicYN="N">B3 virus</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">dilated cardiomyopathy</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">viral myocarditis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35053260</ArticleId><ArticleId IdType="pmc">PMC8773787</ArticleId><ArticleId IdType="doi">10.3390/biom12010112</ArticleId><ArticleId IdType="pii">biom12010112</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta S., Markham D.W., Drazner M.H., Mammen P.P. Fulminant myocarditis. Nat. Clin. Pract. Cardiovasc. Med. 2008;5:693&#x2013;706. doi: 10.1038/ncpcardio1331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpcardio1331</ArticleId><ArticleId IdType="pubmed">18797433</ArticleId></ArticleIdList></Reference><Reference><Citation>Blyszczuk P., M&#xfc;ller-Edenborn B., Valenta T., Osto E., Stellato M., Behnke S., Glatz K., Basler K., L&#xfc;scher T.F., Distler O., et al. Transforming growth factor-&#x3b2;-dependent Wnt secretion controls myofibroblast formation and myocardial fibrosis progression in experimental autoimmune myocarditis. Eur. Heart J. 2017;38:1413&#x2013;1425. doi: 10.1093/eurheartj/ehw116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw116</ArticleId><ArticleId IdType="pubmed">27099262</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Stafford K.A., Sung Y.K. Update on coxsackievirus B3 myocarditis. Curr. Opin. Rheumatol. 2012;24:401&#x2013;407. doi: 10.1097/BOR.0b013e328353372d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e328353372d</ArticleId><ArticleId IdType="pmc">PMC4536812</ArticleId><ArticleId IdType="pubmed">22488075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallwellis-Opara A., D&#xf6;rner A., Poller W.C., Noutsias M., K&#xfc;hl U., Schultheiss H.P., Pauschinger M. Autoimmunological features in inflammatory cardiomyopathy. Clin. Res. Cardiol. 2007;96:469&#x2013;480. doi: 10.1007/s00392-007-0524-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-007-0524-x</ArticleId><ArticleId IdType="pubmed">17503113</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil K.E., Pawlak A., Gil R.J., Frontczak-Baniewicz M., Bil J. The role of invasive diagnostics and its impact on the treatment of dilated cardiomyopathy: A systematic review. Adv. Med. Sci. 2016;61:331&#x2013;343. doi: 10.1016/j.advms.2016.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.advms.2016.07.001</ArticleId><ArticleId IdType="pubmed">27589574</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson E., Savvatis K., Mohiddin S.A., Marelli-Berg F.M. T-cell immunity in myocardial inflammation: Pathogenic role and therapeutic manipulation. Br. J. Pharmacol. 2017;174:3914&#x2013;3925. doi: 10.1111/bph.13613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13613</ArticleId><ArticleId IdType="pmc">PMC5659997</ArticleId><ArticleId IdType="pubmed">27590129</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Rose N.R. Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicity. Methods. 2007;41:118&#x2013;122. doi: 10.1016/j.ymeth.2006.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2006.07.009</ArticleId><ArticleId IdType="pmc">PMC1764911</ArticleId><ArticleId IdType="pubmed">17161308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Xie Y., Shen E., Li G.G., Yu Y., Zhang C.B., Yang Y., Zou Y., Ge J., Chen R., et al. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-&#x3b2;1 signaling in coxsackievirus B3-induced cardiomyopathy. Eur. J. Pharmacol. 2011;658:168&#x2013;174. doi: 10.1016/j.ejphar.2011.02.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2011.02.040</ArticleId><ArticleId IdType="pubmed">21371462</ArticleId></ArticleIdList></Reference><Reference><Citation>Guang-Yi C., Li-Sha G., Yue-Chun L. Role of Heart Rate Reduction in the Management of Myocarditis. Curr. Pharm. Des. 2018;24:365&#x2013;378. doi: 10.2174/1381612824666180111105923.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612824666180111105923</ArticleId><ArticleId IdType="pubmed">29332571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong S., Rose N.R., &#x10c;ih&#xe1;kov&#xe1; D. Natural killer cells in inflammatory heart disease. Clin. Immunol. 2017;175:26&#x2013;33. doi: 10.1016/j.clim.2016.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.11.010</ArticleId><ArticleId IdType="pmc">PMC5315604</ArticleId><ArticleId IdType="pubmed">27894980</ArticleId></ArticleIdList></Reference><Reference><Citation>McGarrah R.W., Crown S.B., Zhang G.F., Shah S.H., Newgard C.B. Cardiovascular Metabolomics. Circ. Res. 2018;122:1238&#x2013;1258. doi: 10.1161/CIRCRESAHA.117.311002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.311002</ArticleId><ArticleId IdType="pmc">PMC6029726</ArticleId><ArticleId IdType="pubmed">29700070</ArticleId></ArticleIdList></Reference><Reference><Citation>Ussher J.R., Elmariah S., Gerszten R.E., Dyck J.R. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease. J. Am. Coll. Cardiol. 2016;68:2850&#x2013;2870. doi: 10.1016/j.jacc.2016.09.972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.09.972</ArticleId><ArticleId IdType="pubmed">28007146</ArticleId></ArticleIdList></Reference><Reference><Citation>Halade G.V., Kain V., Tourki B., Jadapalli J.K. Lipoxygenase drives lipidomic and metabolic reprogramming in ischemic heart failure. Metab. Clin. Exp. 2019;96:22&#x2013;32. doi: 10.1016/j.metabol.2019.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2019.04.011</ArticleId><ArticleId IdType="pubmed">30999004</ArticleId></ArticleIdList></Reference><Reference><Citation>Diguet N., Trammell S.A.J., Tannous C., Deloux R., Piquereau J., Mougenot N., Gouge A., Gressette M., Manoury B., Blanc J., et al. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy. Circulation. 2018;137:2256&#x2013;2273. doi: 10.1161/CIRCULATIONAHA.116.026099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.026099</ArticleId><ArticleId IdType="pmc">PMC6954688</ArticleId><ArticleId IdType="pubmed">29217642</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller O.J., Heckmann M.B., Ding L., Rapti K., Rangrez A.Y., Gerken T., Christiansen N., Rennefahrt U.E.E., Witt H., Gonz&#xe1;lez Maldonado S., et al. Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure. Cardiovasc. Res. 2019;115:1296&#x2013;1305. doi: 10.1093/cvr/cvy274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvy274</ArticleId><ArticleId IdType="pubmed">30418544</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Liu H., Gao J., Zhu M., Wang Y., Jiang C., Xu M. Metabolic disorder in the progression of heart failure. Sci. China. Life Sci. 2019;62:1153&#x2013;1167. doi: 10.1007/s11427-019-9548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-019-9548-9</ArticleId><ArticleId IdType="pubmed">31187303</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson U., Ricci R., Hunziker L., Kurrer M.O., Oudit G.Y., Watts T.H., Sonderegger I., Bachmaier K., Kopf M., Penninger J.M. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 2003;9:1484&#x2013;1490. doi: 10.1038/nm960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm960</ArticleId><ArticleId IdType="pubmed">14625544</ArticleId></ArticleIdList></Reference><Reference><Citation>Querejeta R., Varo N., L&#xf3;pez B., Larman M., Arti&#xf1;ano E., Etayo J.C., Mart&#xed;nez Ubago J.L., Gutierrez-Stampa M., Emparanza J.I., Gil M.J., et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation. 2000;101:1729&#x2013;1735. doi: 10.1161/01.CIR.101.14.1729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.101.14.1729</ArticleId><ArticleId IdType="pubmed">10758057</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y., An Y., Li N., Liu B., Wang Y., Tang H. Multiple univariate data analysis reveals the inulin effects on the high-fat-diet induced metabolic alterations in rat myocardium and testicles in the preobesity state. J. Proteome Res. 2013;12:3480&#x2013;3495. doi: 10.1021/pr400341f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr400341f</ArticleId><ArticleId IdType="pubmed">23700965</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieterle F., Ross A., Schlotterbeck G., Senn H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal. Chem. 2006;78:4281&#x2013;4290. doi: 10.1021/ac051632c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac051632c</ArticleId><ArticleId IdType="pubmed">16808434</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen Vollmar A.K., Rattray N.J.W. Normalizing Untargeted Periconceptional Urinary Metabolomics Data: A Comparison of Approaches. Metabolites. 2019;9:198. doi: 10.3390/metabo9100198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo9100198</ArticleId><ArticleId IdType="pmc">PMC6835889</ArticleId><ArticleId IdType="pubmed">31546636</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Tso V.K., Slupsky C.M., Fedorak R.N. Metabolomics and detection of colorectal cancer in humans: A systematic review. Future Oncol. 2010;6:1395&#x2013;1406. doi: 10.2217/fon.10.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fon.10.107</ArticleId><ArticleId IdType="pubmed">20919825</ArticleId></ArticleIdList></Reference><Reference><Citation>Trygg J., Holmes E., Lundstedt T. Chemometrics in metabonomics. J. Proteome Res. 2007;6:469&#x2013;479. doi: 10.1021/pr060594q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr060594q</ArticleId><ArticleId IdType="pubmed">17269704</ArticleId></ArticleIdList></Reference><Reference><Citation>Box G.E. A general distribution theory for a class of likelihood criteria. Biometrika. 1949;36:317&#x2013;346. doi: 10.1093/biomet/36.3-4.317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/36.3-4.317</ArticleId><ArticleId IdType="pubmed">15402070</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloarec O., Dumas M.E., Trygg J., Craig A., Barton R.H., Lindon J.C., Nicholson J.K., Holmes E. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal. Chem. 2005;77:517&#x2013;526. doi: 10.1021/ac048803i.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ac048803i</ArticleId><ArticleId IdType="pubmed">15649048</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong J., Soufan O., Li C., Caraus I., Li S., Bourque G., Wishart D.S., Xia J. MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 2018;46:W486&#x2013;W494. doi: 10.1093/nar/gky310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky310</ArticleId><ArticleId IdType="pmc">PMC6030889</ArticleId><ArticleId IdType="pubmed">29762782</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia J., Broadhurst D.I., Wilson M., Wishart D.S. Translational biomarker discovery in clinical metabolomics: An introductory tutorial. Metabolomics. 2013;9:280&#x2013;299. doi: 10.1007/s11306-012-0482-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-012-0482-9</ArticleId><ArticleId IdType="pmc">PMC3608878</ArticleId><ArticleId IdType="pubmed">23543913</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J., Huang C. Nuclear magnetic resonance-based tissue metabolomic analysis clarifies molecular mechanisms of gastric carcinogenesis. Cancer Sci. 2020;111:3195&#x2013;3209. doi: 10.1111/cas.14443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.14443</ArticleId><ArticleId IdType="pmc">PMC7469815</ArticleId><ArticleId IdType="pubmed">32369664</ArticleId></ArticleIdList></Reference><Reference><Citation>Goeman J.J., B&#xfc;hlmann P. Analyzing gene expression data in terms of gene sets: Methodological issues. Bioinformatics. 2007;23:980&#x2013;987. doi: 10.1093/bioinformatics/btm051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btm051</ArticleId><ArticleId IdType="pubmed">17303618</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopaschuk G.D., Folmes C.D., Stanley W.C. Cardiac energy metabolism in obesity. Circ. Res. 2007;101:335&#x2013;347. doi: 10.1161/CIRCRESAHA.107.150417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.107.150417</ArticleId><ArticleId IdType="pubmed">17702980</ArticleId></ArticleIdList></Reference><Reference><Citation>Maneikyte J., Bausys A., Leber B. Dietary Glycine Prevents FOLFOX Chemotherapy-Induced Heart Injury: A Colorectal Cancer Liver Metastasis Treatment Model in Rats. Nutrients. 2020;12:2634. doi: 10.3390/nu12092634.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12092634</ArticleId><ArticleId IdType="pmc">PMC7551625</ArticleId><ArticleId IdType="pubmed">32872376</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopaschuk G.D., Karwi Q.G., Ho K.L., Pherwani S., Ketema E.B. Ketone metabolism in the failing heart. Biochim. Et Biophys. Acta Mol. Cell Biol. Lipids. 2020;1865:158813. doi: 10.1016/j.bbalip.2020.158813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2020.158813</ArticleId><ArticleId IdType="pubmed">32920139</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwell A.A., Gopal K., Ussher J.R. Myocardial Energy Metabolism in Non-ischemic Cardiomyopathy. Front. Physiol. 2020;11:570421. doi: 10.3389/fphys.2020.570421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.570421</ArticleId><ArticleId IdType="pmc">PMC7526697</ArticleId><ArticleId IdType="pubmed">33041869</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzsch C., Liao Q., Steen S., Algotsson L. Myocardial glycerol release, arrhythmias and hemodynamic instability during regional ischemia-reperfusion in an open chest pig model. Acta Anaesthesiol. Scand. 2006;50:99&#x2013;107. doi: 10.1111/j.1399-6576.2005.00877.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2005.00877.x</ArticleId><ArticleId IdType="pubmed">16451157</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson P., Nordstr&#xf6;m J., Harms H.J., Lubberink M., Gadler F., S&#xf6;rensen J., M&#xf6;rner S. Positron emission tomography ((15)O-water, (11)C-acetate, (11)C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy. IJC Heart Vasc. 2020;26:100452. doi: 10.1016/j.ijcha.2019.100452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2019.100452</ArticleId><ArticleId IdType="pmc">PMC7046493</ArticleId><ArticleId IdType="pubmed">32140548</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Xiong Z., Yan W., Gao E., Cheng H., Wu G., Liu Y., Zhang L., Li C., Wang S., et al. Branched chain amino acids exacerbate myocardial ischemia/reperfusion vulnerability via enhancing GCN2/ATF6/PPAR-&#x3b1; pathway-dependent fatty acid oxidation. Theranostics. 2020;10:5623&#x2013;5640. doi: 10.7150/thno.44836.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.44836</ArticleId><ArticleId IdType="pmc">PMC7196282</ArticleId><ArticleId IdType="pubmed">32373236</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura Y., Okumura T., Kazama S., Shibata N., Oishi H., Arao Y., Kuwayama T., Kato H., Yamaguchi S., Hiraiwa H., et al. Usefulness of Plasma Branched-Chain Amino Acid Analysis in Predicting Outcomes of Patients with Nonischemic Dilated Cardiomyopathy. Int. Heart J. 2020;61:739&#x2013;747. doi: 10.1536/ihj.20-010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.20-010</ArticleId><ArticleId IdType="pubmed">32684600</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Yang J., Lyu Q., Wu G., Lin S., Yang Q. Taurine attenuates isoproterenol-induced H9c2 cardiomyocytes hypertrophy by improving antioxidative ability and inhibiting calpain-1-mediated apoptosis. Mol. Cell. Biochem. 2020;469:119&#x2013;132. doi: 10.1007/s11010-020-03733-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-020-03733-7</ArticleId><ArticleId IdType="pubmed">32304004</ArticleId></ArticleIdList></Reference><Reference><Citation>Bkaily G., Jazzar A., Normand A., Simon Y., Al-Khoury J., Jacques D. Taurine and cardiac disease: State of the art and perspectives. Can. J. Physiol. Pharmacol. 2020;98:67&#x2013;73. doi: 10.1139/cjpp-2019-0313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2019-0313</ArticleId><ArticleId IdType="pubmed">31560859</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao H., Dong L., Feng Y., Wang C., Tong H. The protective effect of L-glutamine against acute Cantharidin-induced Cardiotoxicity in the mice. BMC Pharmacol. Toxicol. 2020;21:71. doi: 10.1186/s40360-020-00449-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40360-020-00449-8</ArticleId><ArticleId IdType="pmc">PMC7528483</ArticleId><ArticleId IdType="pubmed">33004081</ArticleId></ArticleIdList></Reference><Reference><Citation>Strifler G., Tuboly E., G&#xf6;rbe A., Boros M., P&#xe9;cz D., Hartmann P. Targeting Mitochondrial Dysfunction with L-Alpha Glycerylphosphorylcholine. PLoS ONE. 2016;11:e0166682. doi: 10.1371/journal.pone.0166682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0166682</ArticleId><ArticleId IdType="pmc">PMC5115775</ArticleId><ArticleId IdType="pubmed">27861548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann P., Fet N., Garab D., Szab&#xf3; A., Kaszaki J., Srinivasan P.K., Tolba R.H., Boros M. L-&#x3b1;-glycerylphosphorylcholine reduces the microcirculatory dysfunction and nicotinamide adenine dinucleotide phosphate-oxidase type 4 induction after partial hepatic ischemia in rats. J. Surg. Res. 2014;189:32&#x2013;40. doi: 10.1016/j.jss.2013.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2013.12.025</ArticleId><ArticleId IdType="pubmed">24636100</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#x151;k&#xe9;s T., Tuboly E., Varga G., Major L., Ghyczy M., Kaszaki J., Boros M. Protective effects of L-alpha-glycerylphosphorylcholine on ischaemia-reperfusion-induced inflammatory reactions. Eur. J. Nutr. 2015;54:109&#x2013;118. doi: 10.1007/s00394-014-0691-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-014-0691-2</ArticleId><ArticleId IdType="pubmed">24682350</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuboly E., G&#xe1;sp&#xe1;r R., Ibor M.O., G&#xf6;m&#xf6;ri K., Kiss B., Strifler G., Hartmann P., Ferdinandy P., Bartekova M., Boros M., et al. L-Alpha-glycerylphosphorylcholine can be cytoprotective or cytotoxic in neonatal rat cardiac myocytes: A double-edged sword phenomenon. Mol. Cell. Biochem. 2019;460:195&#x2013;203. doi: 10.1007/s11010-019-03580-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-019-03580-1</ArticleId><ArticleId IdType="pmc">PMC6745025</ArticleId><ArticleId IdType="pubmed">31280435</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>